当前位置：首页 > 文献互助 > 互助详情

期刊论文Antibody–Drug Conjugates in Small-Cell Lung Cancer: DLL3, B7-H3, TROP2 and Beyond复制

用户EO9nReo4Hj6s 1小时前 7 求助中帖子自动结束时间: 2026-04-27 11:48:39

1. 文件大小不能超过300M, 允许上传文档或压缩包等

2. 请确保上传文献的真实性、完整性，不得对原文做任何修改

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1016/j.jtho.2026.103726复制

文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1556086426001796复制

其他信息:

出版社: Elsevier BV
作者: Federico Monaca; Igor Gomez-Randulfe; Javier Torres-Jiménez; Muskan Agarwal; Stephen V. Liu; Luis Paz-Ares; Raffaele Califano

上一篇：Benmelstobart plus anlotinib versus pembrolizumab as first-line treatment for PD-L1-positive, advanced non-small-cell lung cancer (CAMPASS): a blinded, randomised, controlled, phase 3 trial

下一篇：Model-based dose selection for phase 3 trials of the selective P2X3 antagonist camlipixant in refractory chronic cough

互助时间线

2026-04-22 11:48:39 [发起求助]

最新发布的求助

Yanxiao Di’naer decoction attenuates metabolic dysfunction-associated steatohepatitis through the regulation of gut microbiota and the metabolism of bile acid 30分钟前

Tangeretin formulated in a self-nano-emulsifying drug-delivery system (SNEDDS) alleviates symptoms of rheumatoid arthritis by antagonizing M1 macrophages polarization 1小时前

Prevention and treatment of inflammatory arthritis with traditional Chinese medicine: Underlying mechanisms based on cell and molecular targets 1小时前

Prevention and treatment of inflammatory arthritis with traditional Chinese medicine: Underlying mechanisms based on cell and molecular targets 1小时前

Updates on the Perioperative Management of Resectable Non–Small Cell Lung Cancer 1小时前

HSR26-260: Comparative Efficacy and Safety of Second-Line Therapies in Relapsed Small-Cell Lung Cancer: A Systematic Review and Pooled Analysis 1小时前

Model-based dose selection for phase 3 trials of the selective P2X3 antagonist camlipixant in refractory chronic cough 1小时前

Antibody–Drug Conjugates in Small-Cell Lung Cancer: DLL3, B7-H3, TROP2 and Beyond 1小时前

Benmelstobart plus anlotinib versus pembrolizumab as first-line treatment for PD-L1-positive, advanced non-small-cell lung cancer (CAMPASS): a blinded, randomised, controlled, phase 3 trial 1小时前

Fulzerasib plus cetuximab in first-line KRAS-mutated non-small-cell lung cancer (KROCUS): a single-arm, multicentre, phase 1b/2 trial 1小时前

Setidegrasib in Advanced Non–Small-Cell Lung Cancer and Pancreatic Cancer 1小时前

Survival outcome of VATS compared with open lobectomy for lung cancer: an individual patient data meta-analysis of randomised trials 1小时前